Document Detail

Nizatidine as maintenance treatment of duodenal ulcer. Clinical results.
MedLine Citation:
PMID:  7863254     Owner:  NLM     Status:  MEDLINE    
In assessing treatments for chronic diseases such as duodenal ulcer (DU), measuring the patient's quality of life (QoL) is as important as objective measures of treatment efficacy. This study was part of a larger study assessing the QoL of patients with DU treated with nizatidine. The aim of this part of the 12-month study was to assess the clinical efficacy and the influence of maintenance therapy with nizatidine on the long-term treatment of patients with healed DU. The trial, which was open, randomized and controlled, was conducted in 177 centres throughout France. A total of 581 patients of 18 years or over with endoscopically confirmed DU were assigned to two groups. The active treatment group received nizatidine 150 mg/day for one year and the control group had no regular treatment. Both groups had free access to antacid tablets, use of which was recorded. Symptomatic relapse was treated with nizatidine 300 mg/day for 6 weeks. Clinical assessments were made every 2 months, at which times patients also recorded their symptoms. The relapse rate in the nizatidine-treated group was significantly lower than in the control group at 6 months (4.5% versus 15.3%; p < 0.0001). At 12 months the difference was still significant (8.0% versus 33.5%; p < 0.001). Antacid consumption was significantly greater in controls than in the nizatidine-treated group (44.7% versus 29.7%; p < 0.001). It is concluded that nizatidine is a safe and effective therapy for preventing DU recurrence in patients with endoscopically confirmed healed ulcers.
E Lerebours; P Michel; P Hochain; I Berkelmans
Related Documents :
2570534 - The effect of h2 antagonists on duration of action of suxamethonium in the parturient.
21275944 - Efficacy of high doses of botulinum toxin a for treating provoked vestibulodynia.
2397974 - Molluscum contagiosum treated with iodine solution and salicylic acid plaster.
6382004 - Cimetidine, cigarette smoking, and recurrence of duodenal ulcer.
17520224 - Treatment for autoimmune pancreatitis: consensus on the treatment for patients with aut...
18201504 - Age as a predictive factor for in-patient admission following day-case shoulder arthros...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Scandinavian journal of gastroenterology. Supplement     Volume:  206     ISSN:  0085-5928     ISO Abbreviation:  Scand. J. Gastroenterol. Suppl.     Publication Date:  1994  
Date Detail:
Created Date:  1995-03-23     Completed Date:  1995-03-23     Revised Date:  2008-02-13    
Medline Journal Info:
Nlm Unique ID:  0437034     Medline TA:  Scand J Gastroenterol Suppl     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  52-5     Citation Subset:  IM    
Groupe de Biochimie et de Physiopathologie Digestive et Nutritionnelle, Hôpital Charles Nicolle, Rouen, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antacids / therapeutic use
Drug Administration Schedule
Duodenal Ulcer / drug therapy,  prevention & control*
Middle Aged
Nizatidine / administration & dosage,  therapeutic use*
Quality of Life
Reg. No./Substance:
0/Antacids; 76963-41-2/Nizatidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A quality of life study in five hundred and eighty-one duodenal ulcer patients. Maintenance versus i...
Next Document:  Effect of nizatidine versus ranitidine on gastric intraluminal prostaglandin release in duodenal ulc...